Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Jacene

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Reply: A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECTCarlos Uribe, Amir Iravani, Bital Savir-Baruch, et al.
Clinical Nuclear Medicine|August 8, 2015
Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical OutcomeSree Harsha Tirumani, Christopher Sakellis, Heather Jacene, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapyRobert F Hobbs, Sébastien Baechler, Richard L Wahl, et al.
Academic Radiology|September 25, 2021
MRI Changes in Breast Skin Following Preoperative Therapy for Patients with Inflammatory Breast CancerEren Yeh, Anna Rives, Faina Nakhlis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-Fluoro-5α-Dihydrotestosterone PET: A Pilot StudyHeather Jacene, Mofei Liu, Su-Chun Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapyWen Wee Ma, Heather Jacene, Dongweon Song, et al.
Journal of Nuclear Medicine Technology|June 14, 2023
Report on the PET/CT Image-Based Radiation Dosimetry of [<sup>18</sup>F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast CancerKeisha C McCall, Mofei Liu, Su-Chun Cheng, et al.
Archives of Otolaryngology--Head & Neck Surgery|January 18, 2006
The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinomaPatrick K Ha, Alia Hdeib, David Goldenberg, et al.
Medical Physics|June 24, 2009
Comparison of organ residence time estimation methods for radioimmunotherapy dosimetry and treatment planning--patient studiesBin He, Richard L Wahl, George Sgouros, et al.
La Radiologia Medica|November 20, 2024
Quantification of normal bone and osseous metastases in castration-resistant prostate cancer using SPECT/CT with xSPECT Quant: prospective imaging sub-study of a phase 2 clinical trial investigating the combination of pembrolizumab plus radium-223 compared to radium-223 aloneMatthew S Robertson, Yating Wang, SuChun Cheng, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Reply: A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECTCarlos Uribe, Amir Iravani, Bital Savir-Baruch, et al.
Clinical Nuclear Medicine|August 8, 2015
Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical OutcomeSree Harsha Tirumani, Christopher Sakellis, Heather Jacene, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapyRobert F Hobbs, Sébastien Baechler, Richard L Wahl, et al.
Academic Radiology|September 25, 2021
MRI Changes in Breast Skin Following Preoperative Therapy for Patients with Inflammatory Breast CancerEren Yeh, Anna Rives, Faina Nakhlis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-Fluoro-5α-Dihydrotestosterone PET: A Pilot StudyHeather Jacene, Mofei Liu, Su-Chun Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapyWen Wee Ma, Heather Jacene, Dongweon Song, et al.
Journal of Nuclear Medicine Technology|June 14, 2023
Report on the PET/CT Image-Based Radiation Dosimetry of [<sup>18</sup>F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast CancerKeisha C McCall, Mofei Liu, Su-Chun Cheng, et al.
Archives of Otolaryngology--Head & Neck Surgery|January 18, 2006
The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinomaPatrick K Ha, Alia Hdeib, David Goldenberg, et al.
Medical Physics|June 24, 2009
Comparison of organ residence time estimation methods for radioimmunotherapy dosimetry and treatment planning--patient studiesBin He, Richard L Wahl, George Sgouros, et al.
La Radiologia Medica|November 20, 2024
Quantification of normal bone and osseous metastases in castration-resistant prostate cancer using SPECT/CT with xSPECT Quant: prospective imaging sub-study of a phase 2 clinical trial investigating the combination of pembrolizumab plus radium-223 compared to radium-223 aloneMatthew S Robertson, Yating Wang, SuChun Cheng, et al.
Pageof 7